Posted by Michael Wonder on 03 Nov 2020
Department publishes revised agenda for November 2020 PBAC meeting
3 November 2020 - One late change ahead of tomorrow's meeting.
The change is a withdrawal as opposed to the addition of an item or the revision of an item.
The major submission for filgotinib has been withdrawn. This should not come as a major surprise given it was rejected by the US FDA in August 2020 which was after the cut-off date for major submissions for the November 2020 PBAC meeting.
